BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:VB19055 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of VB19055\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07833098-578@assetmemo.bio
DTSTAMP:20261121T004524Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:VB19055: Phase 2 readout est. (NCT07833098)
DESCRIPTION:VB19055\, phase 2\, Hypertension.\nStudy: A Phase II Study of V
 B19055 in Uncontrolled or Resistant Hypertension\nEstimated primary comple
 tion: December 2027. This is a ClinicalTrials.gov estimate\, not a confirm
 ed readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/
 vb19055#upcoming-events\nRegistry record: https://clinicaltrials.gov/study
 /NCT07833098
URL:https://assetmemo.bio/drug/vb19055#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
